# A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Subjects With Osteoarthritis Knee Pain

> **NCT02318407** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 24 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** AMG 403
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02318407
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02318407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02318407, "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Subjects With Osteoarthritis Knee Pain". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02318407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*